Physician profile
John Fredrick Lund
NPI 1477578557
$874.22
in general payments reported to CMS, 2019-2025
9 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $58.72 · 2021: $63.17 · 2022: $360 · 2023: $67.13 · 2024: $78.21 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $335.56 | 2022-2023 | Carto 3 |
| Medtronic, INC. | $228.06 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $120.30 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $51.32 | 2024-2025 | |
| Medtronic Vascular, INC. | $45.59 | 2020 | |
| Abbott Laboratories | $40.73 | 2020-2022 | |
| Biotronik INC. | $24.10 | 2019 | |
| Bard Peripheral Vascular, INC. | $16.63 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.